BioCentury
ARTICLE | Financial News

Financial tracks

April 16, 2016 2:34 AM UTC

Investment fund Apollo Therapeutics named Richard Butt CEO, effective May 23. Butt was senior director and research project leader in the neuroscience and pain research unit of Pfizer Inc. (NYSE:PFE)....